Maravai LifeSciences Holdings, Inc. MRVI Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed November 7, 2025, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s net debt / EBITDA?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported net debt / EBITDA of 4.2× in Q4 2023.
- How has Maravai LifeSciences Holdings, Inc.'s net debt / EBITDA changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s net debt / EBITDA increased by 5512.3% year-over-year, from -0.1× to 4.2×.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s net debt / EBITDA?
- Over 3 years (2020 to 2023), Maravai LifeSciences Holdings, Inc.'s net debt / EBITDA has grown at a 19.6% compound annual growth rate (CAGR), from 2.4× to 4.2×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.